Haemonetics (HAE) Total Current Liabilities (2010 - 2026)

Haemonetics has reported Total Current Liabilities for 17 years, with the latest figure at $263.2 million in Q2 2026.

• On a quarterly basis, Total Current Liabilities fell 50.46% year-over-year to $263.2 million in Q2 2026; TTM through Jun 2026 was $263.2 million, a 50.46% decrease from a year earlier, with the FY2026 full-year figure at $282.6 million, down 51.12% from the prior year.
• Total Current Liabilities was $263.2 million for Q2 2026 at Haemonetics, down from $282.6 million in the prior quarter.
• The five-year high for Total Current Liabilities was $578.1 million in Q1 2025, with the low at $180.5 million in Q3 2022.
• Average Total Current Liabilities over 5 years is $332.3 million, with a median of $264.2 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Total Current Liabilities surged 113.19% in 2025, then plunged 51.12% in 2026.
• Over 5 years, Total Current Liabilities stood at $226.9 million in 2022, then gained by 15.37% to $261.8 million in 2023, then slipped by 3.26% to $253.2 million in 2024, then soared by 113.19% to $539.9 million in 2025, then sank by 51.24% to $263.2 million in 2026.
• The last three Total Current Liabilities figures came in at $263.2 million (Q2 2026), $282.6 million (Q1 2026), and $539.9 million (Q4 2025), per Business Quant data.